Small Cap Biotech Pick

As an investor you have to love an article like this one. The Motley Fool wonders if CuraGen is "Hiding a Genomic Gem" in the race to find the $1000 genome. Which is important, because it helps with making designer drugs for individual people. At around $3.50, Curagen is worth a look if anything.